ClearanceBrief
Recall Z-0439-2016 ยท JWY Manual Antimicrobial Susceptibility Test Systems

Biomerieux

Etest Piperacillin/tazobactam (4 ug/mL) PTc0.016-256-pack of 30 tests WW Etest is a quantitative technique for determining the antimicrobial susceptibility of Gram-negative and Gram-positive aerobic bacteria.

DateDec 23, 2015 (initiated Nov 19, 2015)
StatusTerminated
ReasonDue to the potential for reporting erroneous results for Piperacillin/Tazobactam; specifically false susceptible results.
Root causeProcess change control
ActionConsignees (Subsidiaries and Distributors) of bioMrieux, impacted by the identified issue, were notified of the FSCA and corrective action (FSCA notification) electronically on November 24th, 2015. Additionally, the bioMrieux United States subsidiary notified US consignees (distributors/end-users) of the FSCA notification via FedEx on December 2nd, 2015.
Quantity5458 units
DistributionWorldwide Distribution- US Nationwide including DC and the states of AK, AL, AR, AZ, CA, CO, CT, FL, GS, HI, IA, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, VT, WA, WI, WV and WY, and the countries of Argentina, Australia, A
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K953223PIPERACILIN TAZOBACTAM 4 UG
Ab Biodisk, Aug 15, 1995